Skip to content

Postoperative Follow-up of Asymptomatic Papillary Microcarcinomas on Patient Survival

Interest of Postoperative Follow-up of Asymptomatic Papillary Microcarcinomas on Patient Survival

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05873361
Acronym
MIPTHYS
Enrollment
500
Registered
2023-05-24
Start date
2023-05-15
Completion date
2027-05-15
Last updated
2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary Carcinoma

Keywords

Papillary Carcinoma, Postoperative, Follow-up

Brief summary

This is a study assessing the interest of post-operative follow-up of asymptomatic papillary microcarcinomas. Today, this post-operative follow-up represents an economic cost and is a source of anxiety for patients. The aim of this study is to determine the global survival of patients with asymptomatic papillary microcarcinoma to assess the interest of a post-operative ultrasound and/or biological follow-up.

Interventions

OTHERQuestionnaire

The questionnaire is about hypocalcemia, dysphonia and anxiety. It will be carried out by phone call for 10 minutes

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with uni or multifocal papillary microcarcinoma (cumulative size of foci \<10mm) asymptomatic or not and who underwent partial or total thyroidectomy from 2012 to 2017. * Non opposition patient * Affiliation to a social security scheme

Exclusion criteria

* Lesion crossing the thyroid capsule, or cervical lymph node involvement clinical or histological cervical lymph node involvement. * Patient under guardianship, curators or safeguard of justice

Design outcomes

Primary

MeasureTime frameDescription
Overall survival10 yearsReview of medical record

Secondary

MeasureTime frameDescription
Surgical complications rate10 yearsDysphonia and hypocalcemia
Detection of recurrence rate10 yearsRecurrence detection by additional examen
Disease control rate10 yearsNo recurrence clinically detected or by additional examen
Anxiety evaluation1 monthLikert scale
Prognostics survival criteria1 monthAge during surgical
Recovery surgical or iratherapie recovery rate10 yearsAnatomopathologic analysis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026